Author:
Achyutuni Kavya G.,Adhikari Sambid,Huang Peishan,Siegel Justin B.
Abstract
ABSTRACTCurrent selective serotonin reuptake inhibitor (SSRI) drugs such as paroxetine, fluoxetine and escitalopram are prescribed for mental health conditions such as anxiety and depression. However, there are still several unpleasant side effects which fuels the need for new designs. In this work, computational studies were conducted to design two novel drug candidates with improved docking scores than paroxetine, an existing SSRI drug. Homology analysis was carried out to determine the suitability of an organism for preclinical trials and revealed laboratory mouse (Mus musculus) to be a good candidate.
Publisher
Cold Spring Harbor Laboratory
Reference25 articles.
1. Depression and Anxiety. Center for Disease Control and Prevention. https://www.cdc.gov/tobacco/campaign/tips/diseases/depression-anxiety.html.
2. X-ray structures and mechanism of the human serotonin transporter
3. A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors;Neuropsychopharmacology,2016
4. Managing Depression in Primary Care;Singapore Med J,2017
5. Dp, W. ; Dj, N. Toxicophores: groups and metabolic routes associated with increased safety risk https://pubmed.ncbi.nlm.nih.gov/11865664/.